programas cribado cancer

Nota bibliográfica cribado c cérvix 2014-04

Wilson ML. The challenges of cervical cancer screening. Am J Clin Pathol. 2014;141(4):453. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24619741. doi: 10.1309/AJCPHTJCYILM5FRF. PMID: 24619741.

Davey DD, Goulart R, Nayar R. 2013 statement on human papillomavirus DNA test utilization. Am J Clin Pathol. 2014;141(4):459–61.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/24619744. doi: 10.1309/AJCPKXBQLWOJ4ZUB. PMID: 24619744.
 
Landy R, Birke H, Castanon A, Sasieni P. Benefits and harms of cervical screening from age 20 years compared with screening from age 25 years. Br J Cancer. 2014;110(7):1841–6.  Available from: http://dx.doi.org/10.1038/bjc.2014.65.
 
Conclusions: To prevent one frank invasive cancer, one would need to do between 12 500 and 40 000 additional screening tests in the age group 20–24 years and treat between 300 and 900 women
 
Baldur-Felskov B, Dehlendorff C, Munk C, Kjaer SK. Early Impact of Human Papillomavirus Vaccination on Cervical Neoplasia—Nationwide Follow-up of Young Danish Women. J Natl Cancer Inst. 2014;106(3).
Available from: http://jnci.oxfordjournals.org/content/106/3/djt460.abstract. doi: 10.1093/jnci/djt460.
 
Conclusions Six years after licensure of the quadrivalent HPV vaccine in Denmark, a reduced risk of cervical lesions is observed at the population level.
balidea
web desarrollada y mantenida por :